Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
CALL
Polaris
PII
$3.63B
| $17.7M | 0.01% |
228,500
+92,300
| +68% | +$8.02M |
|
1102
CALL
Acadia Pharmaceuticals
ACAD
$5.22B
| $17.6M | 0.01% |
554,600
+12,500
| +2% | +$424K |
|
1103
CALL
iShares Select Dividend ETF
DVY
$23.8B
| $17.6M | 0.01% |
205,600
+81,600
| +66% | +$7.04M |
|
1104
PUT
W.W. Grainger
GWW
$61.4B
| $17.6M | 0.01% |
78,200
-12,900
| -14% | -$2.9M |
|
1105
Southwest Airlines
LUV
$20B
| $17.6M | 0.01% |
452,054
-4,370
| -1% | -$166K |
|
1106
CALL
Boston Beer
SAM
$1.92B
| $17.6M | 0.01% |
113,100
+90,500
| +400% | +$15.8M |
|
|
TFCFA
1107
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $17.6M | 0.01% |
724,800
+257,400
| +55% | +$6.58M |
|
1108
CALL
Northrop Grumman
NOC
$77.2B
| $17.5M | 0.01% |
82,000
-11,500
| -12% | -$2.49M |
|
1109
CALL
Domino's
DPZ
$11.5B
| $17.5M | 0.01% |
115,500
+33,000
| +40% | +$4.82M |
|
1110
CALL
Smith & Wesson
SWBI
$611M
| $17.5M | 0.01% |
858,140
+385,357
| +82% | +$8.43M |
|
|
XLNX
1111
DELISTED
Xilinx Inc
XLNX
| $17.5M | 0.01% |
321,812
+236,432
| +277% | +$12.2M |
|
1112
DuPont de Nemours
DD
$18.3B
| $17.5M | 0.01% |
133,201
+82,380
| +162% | +$11M |
|
1113
PUT
PPG Industries
PPG
$25.1B
| $17.5M | 0.01% |
169,100
-48,700
| -22% | -$5.11M |
|
1114
CALL
M&T Bank
MTB
$34.7B
| $17.5M | 0.01% |
150,400
-4,800
| -3% | -$558K |
|
1115
CALL
Estee Lauder
EL
$37.5B
| $17.4M | 0.01% |
196,400
+56,300
| +40% | +$5.13M |
|
1116
PUT
Cracker Barrel
CBRL
$1.28B
| $17.4M | 0.01% |
131,400
+97,600
| +289% | +$15M |
|
1117
CALL
Sony
SONY
$140B
| $17.3M | 0.01% |
2,610,500
+1,357,500
| +108% | +$8.7M |
|
1118
PUT
Consolidated Edison
ED
$39.6B
| $17.3M | 0.01% |
230,000
+50,100
| +28% | +$3.89M |
|
1119
PUT
Banco Santander
SAN
$212B
| $17.3M | 0.01% |
4,091,791
+1,229,426
| +43% | +$5.02M |
|
1120
CALL
Edwards Lifesciences
EW
$52B
| $17.3M | 0.01% |
429,600
-48,300
| -10% | -$1.82M |
|
1121
CALL
Opko Health
OPK
$1.11B
| $17.3M | 0.01% |
1,629,500
+635,900
| +64% | +$6.33M |
|
1122
PUT
iShares MSCI Germany ETF
EWG
$1.73B
| $17.2M | 0.01% |
656,300
-2,737,500
| -81% | -$70.2M |
|
1123
PUT
United States Natural Gas Fund
UNG
$505M
| $17.2M | 0.01% |
128,706
+50,731
| +65% | +$6.7M |
|
1124
PUT
General Dynamics
GD
$102B
| $17.2M | 0.01% |
110,800
+35,400
| +47% | +$5.28M |
|
1125
PUT
TotalEnergies
TTE
$195B
| $17.1M | 0.01% |
359,000
+30,000
| +9% | +$1.43M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.